The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

FOCUS ARTICLE

Will CULPRIT-SHOCK change my practice? The CULPRIT-SHOCK trial: culprit lesion-only PCI vs. multivessel PCI in patients with acute myocardial infarction and cardiogenic shock

EuroIntervention 2018;14:955-958 published online ahead of print September 2018. DOI: 10.4244/EIJY18M09_1

1. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; 2. Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy; 3. Department of Cardiology, Queen Elizabeth Hospital, Birming


Introduction to the session

This summary report aims to capture the content of the session at EuroPCR 2018 that reviewed the implications for clinical practice of the CULPRIT-SHOCK trial, in order to share a critical analysis of the trial and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors.

The CULPRIT-SHOCK study1 tested the hypothesis that percutaneous coronary intervention (PCI) of culprit lesion only, with the option of staged revascularisation of non-culprit lesions, would result in better clinical outcomes than immediate multivessel PCI in patients ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
MITRA-FR: speed bump or end of the road for percutaneous mitral repair in secondary mitral regurgitation?

Latest news